LIFE AND HEALTH INSURANCE INDUSTRY SUPPORTS LOWER PRICING FOR GENERIC DRUGS
News ReleaseRelease Date: 07/17/2017 Staff Reference: Lyne Duhaime
(Montreal, Quebec, July 17, 2017) – The life and health insurance industry in Quebec welcomes Health Minister Gaétan Barrette’s announcement that an agreement has been reached with generic drug manufacturers to significantly lower generic drug prices.
“The insurance industry has always supported lower prices for prescription drugs because this benefits members of supplementary health plans, so we are on board with the Minister’s announcement,” stated President of ACCAP-Quebec Lyne Duhaime. “The details of the agreement are still confidential, but we are very hopeful that we can all work together -- the government, pharmacists and insurers – to make sure that Quebec consumers and plan sponsors all benefit from this initiative.”
About the CLHIA
The CLHIA is a voluntary association whose member companies account for 99 percent of Canada’s life and health insurance business. The industry provides a wide range of financial security products such as life insurance, annuities, pensions and supplementary health insurance to 28 million Canadians. It also holds close to $760 billion of assets in Canada and employs 148,600 Canadians.
For more information, please contact:
Lyne Duhaime, President, ACCAP-Quebec